medroxyprogesterone has been researched along with Bone Cancer in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (69.23) | 18.7374 |
1990's | 9 (23.08) | 18.2507 |
2000's | 3 (7.69) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beaufort, F; Gölles, M | 1 |
Carlino, F; Fiorentini, L; Mariani, G; Minervini, R | 1 |
Ausilli-Cefaro, GP; Minotti, G; Saccheri, S; Trodella, L; Turriziani, A; Venturo, I | 1 |
Beaufort, F; Fereberger, W | 1 |
Canigiula, L; Riundi, R; Scanni, A; Vezzoni, MA | 1 |
Belnome, N; Calbo, L; Di Mauro, S; Melita, P; Navarra, S | 1 |
Busutti, L; Gramellini, M; Martoni, A; Pannuti, F; Piana, E | 1 |
Cataldo, I; Di Fronzo, G; Pizzocaro, G; Valente, M; Vezzoni, P | 1 |
Biagi, R; Colalongo, G; Jafelice, G; Mambelli, M; Martoni, A; Pannuti, F; Pedelini, G; Piana, E; Rocchetta, G | 1 |
Fujisawa, J; Satoh, Y; Uchino, J; Une, Y | 1 |
Bonneterre, J; Leriche, N | 1 |
Fukushima, H; Goya, T; Hanaoka, T; Matsuda, M; Sato, K; Tanaka, R | 1 |
Fukuda, Y; Hirao, S; Kinoshita, H; Koyama, I; Mayumi, K; Takatori, H; Terakura, M; Tsukazaki, Y | 1 |
Kawahara, H; Sakurai, T; Tatematsu, H; Yamamoto, T; Yamataka, K | 1 |
Otsuka, T; Tashiro, S; Terashima, Y | 1 |
Amadori, D; Barbanti, F; Ravaioli, A | 1 |
Bumma, C; Calciati, A; Campio, L; Cuna, GR; Strada, MR | 1 |
Pannuti, F | 1 |
Dorn, W; Gladden, MP; Rankin, EA | 1 |
Sasagawa, I; Satomi, S | 1 |
Clavel, M | 1 |
Andersson, SO; Holmberg, L; Johansson, JE | 1 |
Kawahara, T; Kobayakawa, K; Okamura, Y; Takatsuka, Y; Tsumura, I | 1 |
Bezwoda, WR | 1 |
Harada, N; Kanda, K; Kida, H; Narita, K; Uchimura, M; Waki, S | 1 |
Mackillop, WJ; Pringle, JF | 1 |
Katayama, T; Sasagawa, I; Satomi, S | 1 |
Becher, R; Gerhold, U; Hirche, H; Höffken, K; Miller, AA; Schmidt, CG | 1 |
Inaii, H; Koyama, H; Noguchi, S; Yamamoto, H | 1 |
Barasolo, E; de Pauw, M; de Voogt, HJ; Lardennois, B; Pavone-Macaluso, M; Sylvester, R; Viggiano, G | 1 |
Blossey, HC; Kleeberg, U; Nagel, GA; Wander, HE | 1 |
Blackledge, GR; Latief, T; Morrison, M; Mould, JJ; Spooner, D | 1 |
Baroni, M; Longhi, A; Martoni, A; Pannuti, F; Piana, E | 1 |
Amin, R | 1 |
Clavel, B | 1 |
Anderson, EE; Dees, JE; Grimes, JH; Peterson, LJ | 1 |
Gaujoux, J; Laplane, B; Rathelot, P | 1 |
Ellis, F; Paine, CH; Wright, FW | 1 |
Murphy, GP; Wagle, DG | 1 |
3 review(s) available for medroxyprogesterone and Bone Cancer
Article | Year |
---|---|
[Progestational agents and bone metastasis in breast cancer].
Topics: Aminoglutethimide; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Melengestrol Acetate; Survival Analysis; Tamoxifen | 1997 |
Management of breast cancer with bone metastases.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Estrogens; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Palliative Care; Survival Rate | 1991 |
[Medical treatment of malignant bone tumors (carcinolytics, hormonotherapy, immunotherapy)].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Doxorubicin; Hormones; Humans; Immunity, Cellular; Immunotherapy; Kidney Neoplasms; Leukemia; Lung Neoplasms; Lymphoma; Male; Medroxyprogesterone; Methods; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Prostatic Neoplasms; Testosterone; Thyroid Neoplasms; Viral Interference | 1974 |
6 trial(s) available for medroxyprogesterone and Bone Cancer
Article | Year |
---|---|
[Calcitonin in bone-metastasizing breast carcinoma. Results of a pilot study].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Calcitonin; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Pain, Intractable; Palliative Care; Pilot Projects | 1984 |
[Use of high doses of medroxyprogesterone acetate in the palliative treatment of advanced breast cancer. Clinical experience with 44 cases].
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Palliative Care; Skin Neoplasms | 1977 |
High dose medroxyprogesterone acetate (MPA) treatment in metastatic carcinoma of the breast: a dose-response evaluation.
Topics: Abscess; Adult; Aged; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Remission, Spontaneous; Time Factors | 1978 |
High-dose medroxyprogesterone acetate versus estramustine in therapy-resistant prostatic cancer: a randomised study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Delayed-Action Preparations; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prognosis; Prostatic Neoplasms; Time Factors | 1991 |
Treatment of stage D2 prostatic cancer refractory to or relapsed following castration plus oestrogens. Comparison of aminoglutethimide plus hydrocortisone with medroxyprogesterone acetate plus hydrocortisone.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Diethylstilbestrol; Humans; Hydrocortisone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Staging; Orchiectomy; Postoperative Period; Prostatic Neoplasms; Randomized Controlled Trials as Topic | 1990 |
Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological
Topics: Aged; Bone Neoplasms; Carcinoma; Cardiovascular Diseases; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Europe; Follow-Up Studies; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prostatic Neoplasms; Random Allocation | 1986 |
30 other study(ies) available for medroxyprogesterone and Bone Cancer
Article | Year |
---|---|
Regression of skeletal metastases from hypernephroma following long-term treatment with medroxyprogesterone acetate.
Topics: Adenocarcinoma; Bone Neoplasms; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged | 1982 |
Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report.
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Skin Neoplasms; Tamoxifen | 1982 |
[High-dose gestagen therapy in breast cancer].
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Castration; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Risk; Soft Tissue Neoplasms | 1983 |
Calcification of humeral metastasis of renal adenocarcinoma 8 months after medroxyprogesterone acetate therapy.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Female; Humans; Humerus; Kidney Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate | 1984 |
[Hormone treatment of metastasizing breast carcinoma].
Topics: Bone Neoplasms; Breast Neoplasms; Castration; Estradiol Congeners; Humans; Lung Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Methyltestosterone; Progesterone Congeners; Tamoxifen; Testosterone Congeners | 1981 |
High-dose medroxyprogesterone acetate in advanced male breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Medroxyprogesterone; Sex Factors; Time Factors | 1982 |
Estrogen receptors and MPA treatment in metastatic renal carcinoma. A preliminary report.
Topics: Adult; Aged; Bone Neoplasms; Follow-Up Studies; Humans; Injections, Intramuscular; Kidney Neoplasms; Lymphatic Metastasis; Male; Medroxyprogesterone; Middle Aged; Nephrectomy; Postoperative Care; Receptors, Estrogen; Remission, Spontaneous; Time Factors | 1980 |
[Urinary hydroxyproline in advanced breast carcinoma and response to treatment with medroxyprogesterone acetate (MAP) in high doses].
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Humans; Hydroxyproline; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis | 1980 |
[A case of metastatic breast cancer successfully treated with weekly low-dose epirubicin (EPI), cyclophosphamide (CPA), 5-fluorouracil (5-FU) and medroxyprogesterone (MPA)].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Medroxyprogesterone; Middle Aged; Tamoxifen | 1994 |
[Successful endocrine chemotherapy in patients with multiple bone metastases of breast cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Medroxyprogesterone; Middle Aged; Tamoxifen | 1999 |
[Advanced breast cancer with multiple bone metastases successfully treated with combined chemoendocrine-therapy of CEF (cyclophosphamide, epirubicin, 5-fluorouracil) and 5'-DFUR (5'-deoxy-5-fluorouridine) + MPA (medroxyprogesterone acetate)--a case report
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Epirubicin; Female; Floxuridine; Fluorouracil; Humans; Medroxyprogesterone; Middle Aged; Progesterone Congeners; Treatment Outcome | 2001 |
[Results of treatment based on endocrine therapy for bone metastasis from breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone; Middle Aged; Palliative Care; Progesterone Congeners; Quality of Life; Survival Rate | 2001 |
[A case of long surviving advanced recurrent breast cancer with multiple bone metastases responding to treatment with 5'-DFUR combined with MPA].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Floxuridine; Humans; Mastectomy, Radical; Medroxyprogesterone; Survivors | 2002 |
[Modern prospects in the treatment of cancer of the breast and its metastasis. Medroxyprogesterone in massive doses as an alternative to polychemotherapy].
Topics: Bone Neoplasms; Breast Neoplasms; Drug Therapy, Combination; Female; Hormones; Humans; Medroxyprogesterone; Menopause; Middle Aged; Neoplasm Metastasis | 1977 |
Regression of a renal-cell metastatic osseous lesion following treatment.
Topics: Adenocarcinoma; Bone Neoplasms; Humans; Humerus; Kidney Neoplasms; Male; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Nephrectomy; Semustine; Vinblastine | 1975 |
Effect of high-dose medroxyprogesterone acetate on plasma hormone levels and pain relief in patients with advanced prostatic cancer.
Topics: Adrenocorticotropic Hormone; Aged; Antineoplastic Agents; Bone Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Follicle Stimulating Hormone; Gonadotropins; Growth Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Palliative Care; Prolactin; Prostatic Neoplasms; Thyrotropin | 1990 |
[A case of disseminated breast cancer successfully treated with medroxyprogesterone acetate].
Topics: Adenocarcinoma; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Receptors, Estrogen; Remission Induction | 1990 |
[A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Remission Induction; Tegafur; Uracil | 1990 |
Stage III endometrial carcinoma. A review of 90 cases.
Topics: Adenocarcinoma; Bone Neoplasms; Carcinoma, Squamous Cell; Female; Humans; Medroxyprogesterone; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Radiotherapy Dosage; Retrospective Studies; Time Factors; Uterine Neoplasms | 1985 |
[Remarkable pain relief in the treatment with high-dose medroxyprogesterone acetate in advanced prostatic carcinoma].
Topics: Adrenocorticotropic Hormone; Back Pain; Bone and Bones; Bone Neoplasms; Chlormadinone Acetate; Dehydroepiandrosterone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging | 1989 |
High-dose medroxyprogesterone acetate in advanced breast cancer. Clinical and pharmacokinetic study with a combined oral and intramuscular regimen.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1989 |
[Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Recurrence; Remission Induction; Soft Tissue Neoplasms; Tamoxifen; Weight Gain | 1989 |
Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. A phase II study of the Association of Medical Oncology of the German Cancer Society (AIO).
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Drug Synergism; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Pain | 1986 |
Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: relationship of response to previous treatment.
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged | 1986 |
Medroxyprogesterone acetate at very high doses in postmenopausal advanced breast cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Remission Induction | 1987 |
Complete regression of skeletal metastases from hypernephroma after angioinfarction and medroxyprogesterone acetate therapy.
Topics: Bone Neoplasms; Brain Neoplasms; Carcinoma, Renal Cell; Combined Modality Therapy; Embolization, Therapeutic; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Remission Induction; Renal Artery | 1988 |
Hormonal therapy in metastatic hypernephroma.
Topics: Adenocarcinoma; Adult; Aged; Bone Neoplasms; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Prednisone; Radiography; Testosterone | 1974 |
[Bone metastasis revealing a cancer of the endometrium].
Topics: Adenocarcinoma; Bone Neoplasms; Female; Humans; Ischium; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Prognosis; Pubic Bone; Time Factors; Uterine Neoplasms | 1972 |
The use of progestogen in the treatment of metastatic carcinoma of the kidney and uterine body.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Uterine Neoplasms | 1970 |
Hormonal therapy in advanced renal cell carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Bone Neoplasms; Brain Neoplasms; Female; Humans; Hydroxyprogesterones; Kidney Neoplasms; Lung Neoplasms; Male; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Nephrectomy; Pleural Neoplasms; Prednisone; Radiography; Testosterone | 1971 |